Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancers|April 30, 2021
Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?Daniele Fanale, Lorena Incorvaia, Giuseppe Badalamenti, et al.
Cancers|April 14, 2025
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic StrategyDaniela Sambataro, Sandro Bellavia, Paolo Di Mattia, et al.
Cancers|January 8, 2023
Sodium Propionate Contributes to Tumor Cell Growth Inhibition through PPAR-γ SignalingAlessia Filippone, Giovanna Casili, Sarah Adriana Scuderi, et al.
Cancers|November 19, 2020
A "Lymphocyte MicroRNA Signature" as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic ReprogrammingLorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, et al.
Cancers|February 13, 2025
Brain Metastasis in Endometrial Cancer: A Systematic ReviewDaniela Sambataro, Vittorio Gebbia, Annalisa Bonasera, et al.
Therapeutic Advances in Medical Oncology|March 31, 2022
Safety and effectiveness of gemcitabine for the treatment of classic Kaposi's sarcoma without visceral involvementGiuseppe Badalamenti, Lorena Incorvaia, Laura Algeri, et al.
Therapeutic Advances in Medical Oncology|October 7, 2021
Not all <i>KIT</i> 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)Lorena Incorvaia, Giuseppe Badalamenti, Daniele Fanale, et al.
Frontiers in Oncology|May 4, 2023
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumabLorena Incorvaia, Alessandra Dimino, Laura Algeri, et al.
Pageof 1